Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.

Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD Jr.

Bone. 2008 Apr;42(4):669-80. doi: 10.1016/j.bone.2007.12.006. Epub 2007 Dec 27.

PMID:
18294945
2.

Wnts induce migration and invasion of myeloma plasma cells.

Qiang YW, Walsh K, Yao L, Kedei N, Blumberg PM, Rubin JS, Shaughnessy J Jr, Rudikoff S.

Blood. 2005 Sep 1;106(5):1786-93. Epub 2005 May 10.

3.

PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.

Crowder C, Dahle Ø, Davis RE, Gabrielsen OS, Rudikoff S.

Blood. 2005 Feb 1;105(3):1280-7. Epub 2004 Sep 30.

4.

Wnt signaling in B and T lymphocytes.

Qiang YW, Rudikoff S.

Front Biosci. 2004 Jan 1;9:1000-10. Review.

PMID:
14766426
5.

Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells.

Qiang YW, Yao L, Tosato G, Rudikoff S.

Blood. 2004 Jan 1;103(1):301-8. Epub 2003 Sep 22.

6.

Wnt signaling in B-cell neoplasia.

Qiang YW, Endo Y, Rubin JS, Rudikoff S.

Oncogene. 2003 Mar 13;22(10):1536-45.

PMID:
12629517
7.

An unusual H-Ras mutant isolated from a human multiple myeloma line leads to transformation and factor-independent cell growth.

Crowder C, Kopantzev E, Williams K, Lengel C, Miki T, Rudikoff S.

Oncogene. 2003 Feb 6;22(5):649-59.

PMID:
12569357
8.

IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.

Kopantzev Y, Heller M, Swaminathan N, Rudikoff S.

Oncogene. 2002 Oct 3;21(44):6791-800.

9.
10.
11.
12.

Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.

Li W, Hyun T, Heller M, Yam A, Flechner L, Pierce JH, Rudikoff S.

Cancer Res. 2000 Jul 15;60(14):3909-15.

13.

A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo.

Grey A, Mitnick MA, Masiukiewicz U, Sun BH, Rudikoff S, Jilka RL, Manolagas SC, Insogna K.

Endocrinology. 1999 Oct;140(10):4683-90.

PMID:
10499526
14.

Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia.

Swaminathan N, Lopez-Berestein G, Rudikoff S.

Med Oncol. 1999 Jul;16(2):119-28.

PMID:
10456660
15.

Characterization of two class I genes from the H2-M region: evidence for a new subfamily.

Arepalli SR, Jones EP, Howcroft TK, Carlo I, Wang C, Lindahl KF, Singer DS, Rudikoff S.

Immunogenetics. 1998;47(3):264-71.

PMID:
9435345
16.

Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma.

Kopantzev E, Roschke V, Rudikoff S.

Hum Gene Ther. 1998 Jan 1;9(1):13-9.

PMID:
9458238
17.

Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.

Roschke V, Hausner P, Kopantzev E, Pumphrey JG, Riminucci M, Hilbert DM, Rudikoff S.

Cancer Res. 1998 Feb 1;58(3):535-41.

18.

Characterization of C57BL/6 plasmacytomas lacking a c-myc translocation.

Pumphrey JG, Hausner P, Rudikoff S.

Int J Cancer. 1997 Sep 4;72(5):892-7.

19.

Chromosomal translocations deregulating c-myc are associated with normal immune responses.

Roschke V, Kopantzev E, Dertzbaugh M, Rudikoff S.

Oncogene. 1997 Jun 26;14(25):3011-6.

20.

Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action.

Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, Rudikoff S, Aaronson SA, Varmus HE, Rubin JS.

Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6770-5.

21.

Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity.

Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ.

Toxicol Appl Pharmacol. 1996 Sep;140(1):173-9.

PMID:
8806883
22.

Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway.

Hilbert DM, Migone TS, Kopf M, Leonard WJ, Rudikoff S.

Immunity. 1996 Jul;5(1):81-9.

23.

Repression of the nonclassical MHC class I gene H2-M1 by cis-acting silencer DNA elements.

Howcroft TK, Weissman JD, Rudikoff S, Frels WI, Singer DS.

Immunogenetics. 1996;44(4):268-74.

PMID:
8753857
24.

Interleukin 6 is essential for in vivo development of B lineage neoplasms.

Hilbert DM, Kopf M, Mock BA, Köhler G, Rudikoff S.

J Exp Med. 1995 Jul 1;182(1):243-8.

25.

Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor.

Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ.

Science. 1995 May 5;268(5211):722-6.

PMID:
7732381
26.

T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.

Hilbert DM, Shen MY, Rapp UR, Rudikoff S.

Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):649-53.

27.

Long-term lymphoid reconstitution of SCID mice suggests self-renewing B and T cell populations in peripheral and mucosal tissues.

Hilbert DM, Anderson AO, Holmes KL, Rudikoff S.

Transplantation. 1994 Aug 27;58(4):466-75.

PMID:
8073516
28.

Long-term thymic reconstitution by peripheral CD4 and CD8 single-positive lymphocytes.

Hilbert DM, Holmes KL, Anderson AO, Rudikoff S.

Eur J Immunol. 1993 Oct;23(10):2412-8.

PMID:
8405041
29.

Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice.

Hilbert DM, Pumphrey JG, Troppmair J, Rapp UR, Rudikoff S.

Oncogene. 1993 Jul;8(7):1993-2000.

PMID:
7685514
30.

In vitro culture of primary plasmacytomas requires stromal cell feeder layers.

Degrassi A, Hilbert DM, Rudikoff S, Anderson AO, Potter M, Coon HG.

Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2060-4.

31.

Characterization of a V kappa family in Mus musculus castaneus: sequence analysis.

Henderson TJ, Rudikoff S.

Immunogenetics. 1993;37(6):426-36.

PMID:
8436417
32.

Characterization of a V kappa family in Mus musculus castaneus: expansion at the subset level.

Henderson TJ, Rudikoff S.

Immunogenetics. 1993;37(6):415-25.

PMID:
8436416
34.

Instability of immunoglobulin genes in S107 cell line.

Shin SU, DePinho R, Zack DJ, Rudikoff S, Scharff MD.

Somat Cell Mol Genet. 1991 May;17(3):259-76.

PMID:
1904631
35.

Expression of a class I MHC transgene: regulation by a tissue-specific negative regulatory DNA sequence element.

Frels WI, Bordallo C, Golding H, Rosenberg A, Rudikoff S, Singer DS.

New Biol. 1990 Nov;2(11):1024-33.

PMID:
2101629
36.

Sequence and structure of Clp P, the proteolytic component of the ATP-dependent Clp protease of Escherichia coli.

Maurizi MR, Clark WP, Katayama Y, Rudikoff S, Pumphrey J, Bowers B, Gottesman S.

J Biol Chem. 1990 Jul 25;265(21):12536-45.

37.

T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells.

Hilbert DM, Cancro MP, Scherle PA, Nordan RP, Van Snick J, Gerhard W, Rudikoff S.

J Immunol. 1989 Dec 15;143(12):4019-24.

PMID:
2480384
38.

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.

McIntosh JK, Jablons DM, Mulé JJ, Nordan RP, Rudikoff S, Lotze MT, Rosenberg SA.

J Immunol. 1989 Jul 1;143(1):162-7.

PMID:
2499626
39.

The murine Il-6 gene maps to the proximal region of chromosome 5.

Mock BA, Nordan RP, Justice MJ, Kozak C, Jenkins NA, Copeland NG, Clark SC, Wong GG, Rudikoff S.

J Immunol. 1989 Feb 15;142(4):1372-6.

PMID:
2563387
40.

Purification and characterization of a newly identified growth factor specific for epithelial cells.

Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA.

Proc Natl Acad Sci U S A. 1989 Feb;86(3):802-6.

41.

The role of plasmacytoma growth factor in the in vitro responses of murine plasmacytoma cells.

Nordan RP, Mock BA, Neckers LM, Rudikoff S.

Ann N Y Acad Sci. 1989;557:200-5.

PMID:
2786694
42.

Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state.

Jablons DM, McIntosh JK, Mulé JJ, Nordan RP, Rudikoff S, Lotze MT.

Ann N Y Acad Sci. 1989;557:157-60; discussion 160-1. No abstract available.

PMID:
2472087
43.

The two-component, ATP-dependent Clp protease of Escherichia coli. Purification, cloning, and mutational analysis of the ATP-binding component.

Katayama Y, Gottesman S, Pumphrey J, Rudikoff S, Clark WP, Maurizi MR.

J Biol Chem. 1988 Oct 15;263(29):15226-36.

44.

Interaction and sequence diversity among T15 VH genes in CBA/J mice.

Ferguson SE, Rudikoff S, Osborne BA.

J Exp Med. 1988 Oct 1;168(4):1339-49.

45.

Antibodies to beta(1,6)-D-galactan: proteins, idiotypes and genes.

Rudikoff S.

Immunol Rev. 1988 Oct;105:97-111. Review. No abstract available.

PMID:
3058582
46.

Modern evolution of a single-copy gene: the immunoglobulin C kappa locus in wild mice.

Jouvin-Marche E, Cuddihy A, Butler S, Hansen JN, Fitch WM, Rudikoff S.

Mol Biol Evol. 1988 Sep;5(5):500-11.

PMID:
3143045
47.

Evolution of the IgA heavy chain gene in the genus Mus.

Osborne BA, Golde TE, Schwartz RL, Rudikoff S.

Genetics. 1988 Aug;119(4):925-31.

48.

Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1.

Davidson WF, Pierce JH, Rudikoff S, Morse HC 3rd.

J Exp Med. 1988 Jul 1;168(1):389-407.

49.

Characterization of a new subfamily of class I genes in the H-2 complex of the mouse.

Singer DS, Hare J, Golding H, Flaherty L, Rudikoff S.

Immunogenetics. 1988;28(1):13-21.

PMID:
3378834
50.

Structure and expression of class I MHC genes in the miniature swine.

Singer DS, Ehrlich R, Satz L, Frels W, Bluestone J, Hodes R, Rudikoff S.

Vet Immunol Immunopathol. 1987 Dec;17(1-4):211-21. Review.

PMID:
3124334

Supplemental Content

Loading ...
Support Center